Qidni Labs is aiming to serve millions of patients with kidney failure outside of dialysis clinics and without owning any dialysis clinics. We achieve this goal through the miniaturization of blood purification technology and creating wearable/portable blood purification devices with a cloud-based remote patient monitoring system, which replaces most of the tasks performed at the dialysis clinics. We are now raising our Series A.
There are over 700,000 dialysis patients in the US and dialysis costs $82,000 per patient, per year in the US alone. Dialysis is reimbursed through Medicare and Medicaid. The US government announced a new policy in 2019 which wants 80% of new dialysis patients to be using “home” dialysis or receive a kidney for transplantation. We are lucky to be one of only a few companies in the world developing the next generation of dialysis technology that can be used outside of dialysis clinics, including in patients’ homes.